Although BMP2 is upregulated after cerebral ischemia [17], its function as an endogenous neuroprotectant is controversial since recombinant soluble Noggin, an antagonist of BMP2, BMP4 and BMP7, demonstrates neuroprotective effects in models of stroke [18-20]. Here, BMP2 is linked to Cerebral ischemia.